The Oncidium foundation was created in 2011 to promote the development of nuclear medicine therapy through the dissemination of reliable and complete information for patients. Radiotherapeutics and radiotheranostics represent a new class of drugs that can be used for patient suffering from incurable cancers.
The Foundation's priority include promoting the awareness among patients and physicians, investing in research and scholarship, supporting and financing the development of new radiopharmaceuticals for therapy, supporting clinical best practice and improving access to patients.
Company Details
- Employees
- 54
- Founded
- -
- Address
- Brussels, Brussels 1160, Be
- Industry
- Non-Profit Organizations
- Website
- oncidium-life.org
- HQ
- Brussels, Brussels
- Competitors
- Isotopia Molecular Imaging ltd, Nuclear Medicine Europe, Fundação Oncidium - Brazil, IBA RadioPharma Solutions, Society of Nuclear Medicine and Molecular Imaging (SNMMI), Clarity Pharmaceuticals, European Association of Nuclear Medicine (EANM), Radiopharm Theranostics, Nucleus RadioPharma, IBA.
Oncidium Foundation Questions
Oncidium Foundation's website is oncidium-life.org
Oncidium Foundation's LinkedIn profile is https://be.linkedin.com/company/oncidium-foundation
Oncidium Foundation has
54 employees.
View email and phone details for 54
employees at Oncidium Foundation.
Oncidium Foundation's industry is
Non-profit Organizations
Oncidium Foundation's top competitors are
Isotopia Molecular Imaging Ltd,
Nuclear Medicine Europe,
Fundação Oncidium - Brazil,
Iba Radiopharma Solutions,
Society Of Nuclear Medicine And Molecular Imaging (Snmmi),
Clarity Pharmaceuticals,
European Association Of Nuclear Medicine (Eanm),
Radiopharm Theranostics,
Nucleus Radiopharma,
Iba.
Oncidium Foundation's categories are Non-profit Organizations
Oncidium Foundation's founding year is 2011
